Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy

Oral tyrosine kinase inhibitors (TKIs) against epidermal growth factor receptor (EGFR) family have been introduced into the clinic to treat human malignancies for decades. Despite superior properties of EGFR-TKIs as small molecule targeted drugs, their applications are still restricted due to their...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asian J Pharm Sci
Main Authors: Zhou, Xiaohan, Shi, Kun, Hao, Ying, Yang, Chengli, Zha, Ruoyu, Yi, Cheng, Qian, Zhiyong
Formato: Artigo
Idioma:Inglês
Publicado em: Shenyang Pharmaceutical University 2020
Assuntos:
Review article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066044/
https://ncbi.nlm.nih.gov/pubmed/32175016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajps.2019.06.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados